Adrián Vilalta
Vical
San Diego
CA 92121
USA
Name/email consistency: high
- Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge. Vilalta, A., Jimenez, G., Rusalov, D., Planchon, R., Lalor, P., Carner, K., Chaplin, J.A., Komai, M., Manthorpe, M., Kaslow, D.C., Rolland, A. Hum. Gene Ther. (2007)
- I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration. Vilalta, A., Mahajan, R.K., Hartikka, J., Rusalov, D., Martin, T., Bozoukova, V., Leamy, V., Hall, K., Lalor, P., Rolland, A., Kaslow, D.C. Hum. Gene Ther. (2005)
- II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential. Vilalta, A., Mahajan, R.K., Hartikka, J., Leamy, V., Martin, T., Rusalov, D., Bozoukova, V., Lalor, P., Hall, K., Kaslow, D.C., Rolland, A. Hum. Gene Ther. (2005)
- Rabbit EPO gene and cDNA: expression of rabbit EPO after intramuscular injection of pDNA. Vilalta, A., Wu, D., Margalith, M., Hobart, P. Biochem. Biophys. Res. Commun. (2001)